1. Market Research
  2. > Warner Chilcott Plc - Product Pipeline Review - 2013

Warner Chilcott Plc - Product Pipeline Review - 2013

  • July 2013
  • -
  • Global Markets Direct
  • -
  • 31 pages

Warner Chilcott Plc - Product Pipeline Review - 2013

Summary

Global Markets Direct’s pharmaceuticals report, “Warner Chilcott Plc - Product Pipeline Review - 2013” provides data on the Warner Chilcott Plc’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Warner Chilcott Plc’s corporate website, SEC filings, investor presentations and featured press releases, both from Warner Chilcott Plc and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Warner Chilcott Plc - Brief Warner Chilcott Plc overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Warner Chilcott Plc human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Warner Chilcott Plc with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Warner Chilcott Plc’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Warner Chilcott Plc’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Warner Chilcott Plc in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Warner Chilcott Plc’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Warner Chilcott Plc.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Warner Chilcott Plc and identify potential opportunities in those areas.

Table Of Contents

Warner Chilcott Plc - Product Pipeline Review - 2013
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Warner Chilcott Plc Snapshot 4
Warner Chilcott Plc Overview 4
Key Information 4
Key Facts 4
Warner Chilcott Plc - Research and Development Overview 5
Key Therapeutic Areas 5
Warner Chilcott Plc - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Warner Chilcott Plc - Pipeline Products Glance 10
Warner Chilcott Plc - Late Stage Pipeline 10
Filing rejected/Withdrawn Products/Combination Treatment Modalities 10
Phase III Products/Combination Treatment Modalities 11
Warner Chilcott Plc Clinical Stage Pipeline Products 12
Phase II Products/Combination Treatment Modalities 12
Warner Chilcott Plc - Drug Profiles 13
alprostadil 13
Product Description 13
Mechanism of Action 13
RandD Progress 13
estradiol acetate 14
Product Description 14
Mechanism of Action 14
RandD Progress 14
sarecycline hydrochloride 15
Product Description 15
Mechanism of Action 15
RandD Progress 15
udenafil 16
Product Description 16
Mechanism of Action 16
RandD Progress 16
Warner Chilcott Plc - Pipeline Analysis 17
Warner Chilcott Plc - Pipeline Products by Therapeutic Class 17
Warner Chilcott Plc - Pipeline Products By Target 19
Warner Chilcott Plc - Pipeline Products by Route of Administration 20
Warner Chilcott Plc - Pipeline Products By Mechanism of Action 21
Warner Chilcott Plc - Recent Pipeline Updates 22
Warner Chilcott Plc - Dormant Projects 25
Warner Chilcott Plc - Company Statement 26
Warner Chilcott Plc - Locations And Subsidiaries 29
Head Office 29
Other Locations and Subsidiaries 29
Appendix 30
Methodology 30
Coverage 30
Secondary Research 30
Primary Research 30
Expert Panel Validation 30
Contact Us 31
Disclaimer 31

List of Tables

Warner Chilcott Plc, Key Information 4
Warner Chilcott Plc, Key Facts 4
Warner Chilcott Plc - Pipeline by Indication, 2013 7
Warner Chilcott Plc - Pipeline by Stage of Development, 2013 8
Warner Chilcott Plc - Monotherapy Products in Pipeline, 2013 9
Warner Chilcott Plc - Filing rejected/Withdrawn, 2013 10
Warner Chilcott Plc - Phase III, 2013 11
Warner Chilcott Plc - Phase II, 2013 12
Warner Chilcott Plc - Pipeline By Therapeutic Class, 2013 18
Warner Chilcott Plc - Pipeline By Target, 2013 19
Warner Chilcott Plc - Pipeline By Route of Administration, 2013 20
Warner Chilcott Plc - Pipeline Products By Mechanism of Action, 2013 21
Warner Chilcott Plc - Recent Pipeline Updates, 2013 22
Warner Chilcott Plc - Dormant Developmental Projects,2013 25
Warner Chilcott Plc, Subsidiaries 29

List of Figures

Warner Chilcott Plc - Pipeline by Indication, 2013 6
Warner Chilcott Plc - Pipeline by Stage of Development, 2013 8
Warner Chilcott Plc - Monotherapy Products in Pipeline, 2013 9
Warner Chilcott Plc - Pipeline By Therapeutic Class, 2013 17

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.